logologologologo
  • SERVICES
    • HOW IT WORKS
    • COSMETIC CRYO-FAT PROGRAM
    • ADULT STEM CELL PROGRAMS
  • PRODUCTS
    • TISSUE HARVESTING SYSTEM
    • STEM CELL MEDIAS
    • STEM CELL LINES
  • INVESTORS
    • ABOUT US
    • STOCK INFORMATION
    • PRESS RELEASES
    • OUR LEADERSHIP
    • LICENSING PARTNERS
  • NEWS
  • CONTACT US

Personal Cell Sciences U Autologous Skin Care Listed on Forbes Top 10 Fashion and Beauty Startups for 2012

December 4, 2012

EATONTOWN, N.J., Dec. 4, 2012 (GLOBE NEWSWIRE) — American CryoStem Corporation (OTCQB:CRYO) is pleased to announce that Personal Cell Sciences (PCS), U Autologous Skin Care products have been listed on Forbes.com “Top 10 Fashion and Beauty Startups for 2012” released on November 27, 2012.

These cutting edge innovative products were developed by PCS, through a previously announced manufacturing and processing collaboration between American CryoStem and Personal Cell Sciences. To create the U-Autologous product formulation, the customers Adipose Tissue (fat) is collected through a participating physician using American CryoStem’s proprietary, adipose tissue collection system and processed into stem cells according to CRYO’s FDA compliant Standard Operating Procedures (SOP’s).

Additionally, under the agreement with PCS, CRYO utilizes its patented animal-free media to culture an individual’s stem cells to create the key ingredient in the PCS anti-aging formulation, Autokine-CMTM, which contains the individual’s proteins, growth factors and cytokines collected from their Adipose Derived Stem Cells.

“We are truly excited that the industry recognized our cutting edge science and innovative methodologies. The positive feedback we have received since the launch of the PCS, U-Autologous this year has reinforced the desire for personalized adult stem cell based products and services. We look forward to an excellent 2013 as the PCS brand begins to build awareness throughout the industry as the leading science based adult stem cell skin care company,” stated John DiFolco, Director of Marketing for PCS.

“American CryoStem provides the highest quality tissue collection, processing, storage and cellular expansion services available today. Through the continued efforts of our scientific staff and the use of our patented animal free cell culture products and processing methods we have been able to support the manufacturing needs of truly unique companies like PCS,” stated Anthony Dudzinski COO of American CryoStem Corporation. “We look forward to expanding our R&D and manufacturing partnerships with other companies participating in the Life Sciences and Regenerative Medicine Industry.”

About American CryoStem: American CryoStem Corporation (OTCQB:CRYO) is a leading biotech company focused on marketing its clinical processing services and patented products for Adipose Tissue (fat) and Adipose Derived Adult Stem Cells. Our clinical tissue processing, patented cell culture media products and tissue storage platform supports cosmetic and Regenerative Medicine applications being developed globally. The Company provides high quality, clinically processed viable cells, while at the same time developing cutting edge applications, therapies, patented laboratory products and services for consumer and commercial applications.

About Personal Cell Sciences: www.personalcellsciences.com

Investor Relations Contact:
American CryoStem Corporation
732-747-1007

www.americancryostem.com

Share

Related posts

January 6, 2021

American CryoStem Enters into a Cooperative Research and Development Agreement (CRADA) to Develop Standardized Treatment Protocols


Read more
December 1, 2020

American CryoStem Announces Patient Recruitment and Additional Sub-Investigator for its Post-Concussion Syndrome (PCS) Phase I Clinical Trial


Read more
September 23, 2020

American CryoStem Announces: FDA has cleared its Investigational New Drug (IND) for Post-Concussion Syndrome for Phase I Clinical Trial


Read more

About American CryoStem Corporation

American CryoStem (CRYO) is a leading developer, manufacturer, and marketer of life-enhancing, adipose tissue (fat) based stem cell technologies. The company offers a proprietary tissue collection, processing and cryo-storage platform for (current or future) regenerative medicine applications using adult stem cells to address the impact of aging, injury and other disorders.

© 2018 American CryoStem Corporation | A Publicly Traded Company (CRYO)
  • Physicians
  • Licensing & Partners
  • OTCBB: CRYO